Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to predict lung disease in kids using biomarkers

NCT ID NCT07232550

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This observational study will analyze samples from 160 children with asthma, protracted bacterial bronchitis, or chronic cough to find biomarkers that predict disease progression and treatment response. Participants will undergo a bronchoscopy to collect lung fluid and tissue samples. The goal is to improve understanding and management of these respiratory conditions in children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2035

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from among patients hospitalized in the University Clinical Center of the Medical University of Warsaw, Department of Pediatric Pulmonology and Allergology, and in the Medical University of Lodz, Department of Pediatric Pulmonology

Ages

Up to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age at the beginning of the study 0-17 years old * Clinical indication and qualification by the attending physician for fiberoptic bronchoscopy under general anesthesia: * Obstruction of the airways: * Suspicion of foreign body aspiration * Persistent stridor * Abnormal result of functional tests of respiratory system - flattening of inspiratory or expiratory curve, presence of restriction (tested vital capacity \<5 percentile) or irreversible obstruction (persistence of Tiffneau index \<5 percentile despite administration of bronchodilators) * Radiological findings located in the course of the larynx, trachea or bronchi * Persistent atelectasis on subsequent radiological examinations * Persistent cough \>4 weeks * Hemoptysis * Suspected laryngomalacia or tracheobronchomalacia * Suspected tracheoesophageal fistula * Persistent dyspnea unresponsive to anti-asthmatic treatment used for min. 2 months, with no other identifiable causes * Radiologically detected mediastinal abnormalities * Suspected presence of a vascular ring * Presence of excessive secretions that are impossible for the patient to expectorate * Fine needle biopsy of cystic lesions * Obtained consent from patient/legal guardian for participation in the study Exclusion Criteria: * Active acute respiratory infection up to 4 weeks before the procedure * Taking antibiotics or systemic glucocorticosteroids up to 4 weeks before the procedure * Patients with very severe comorbidities (congenital immunodeficiencies, genetic disorders, neurological or neuromuscular diseases, cancer, severe congenital heart defects, heart failure, liver failure, inflammatory bowel disease, celiac disease) * Patients with blood clotting disorders * Children with diagnosed respiratory diseases other than asthma and protracted bacterial bronchitis - including interstitial diseases, tuberculosis, inflammation of small and medium-sized blood vessels * Patients for whom \>48 hours have passed between suspicion of foreign body aspiration and interventional bronchoscopy * Children with foreign body aspiration having a foreign body located in the trachea

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma in children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Żwirki i Wigury 63A

    RECRUITING

    Warsaw, 02-091, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.